The concept of target features in schizophrenia research

Acta Psychiatrica Scandinavica, Supplement

Volumn 99, Issue 395, 1999, Pages 2-11

  Tsuang, Ming T ^a,b,c,d   Faraone, S V ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Brockton W Roxbury US Dept V   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Genetics; Psychopathology; Schizophrenia

Indexed keywords

ATTENTION; CLINICAL RESEARCH; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; EVOKED AUDITORY RESPONSE; EYE TRACKING; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; MENTAL STRESS; NEUROBIOLOGY; NEUROPSYCHOLOGICAL TEST; PATHOGENESIS; PERSONALITY DISORDER; SCHIZOPHRENIA; THOUGHT DISORDER; BRAIN; CHILD; CHILD DEVELOPMENT; DISEASE COURSE; ENVIRONMENT; FAMILY HEALTH; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; REVIEW;

BRAIN; CHILD; CHILD DEVELOPMENT; CHILD OF IMPAIRED PARENTS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; ENVIRONMENT; FAMILY HEALTH; HUMANS; NEUROPSYCHOLOGICAL TESTS; RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032616038     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1999.tb05977.x     Document Type: Conference Paper

References (119)

1. MEEHL PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol 1962;17:827-838.
2. GOTTESMAN II. Schizophrenia genesis: the origin of madness. New York: Freeman, 1991.
3. MEEHL PE. Schizotaxia revisited. Arch Gen Psychiatry 1989;46:935-944.
4. PULVER AE, KARAYIORGOU M, WOLYNEIC P et al. Sequential strategy to identify a susceptibility gene for schizophrenia on chromosome 22q12-q13.1. Part 1. Am J Med Genet Neuropsychiatr Genet 1994;54:36-43.
5. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Am J Med Genet Neuropsychiatr Genet 1996;67:580-594.
6. KENDLER KS. Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry 1983;140:1413-1425.
7. TSUANG MT, LYONS MJ, FARAONE SV. Heterogeneity of schizophrenia: conceptual models and analytic strategies. Br J Psychiatry 1990;156:17-26.
8. TSUANG MT, FARAONE SV. The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 1995;17:161-175.
9. GOTTESMAN II, MCGUE M. Mixed and mixed-up models for the transmission of schizophrenia. In: CICHETTE D, ed. Thinking clearly about psychology: essays in honor of Paul E. Meehl. Minneapolis: University of Minnesota Press, 1990:295-312.
10. GOTTESMAN II, CAREY G, HANSON DR. Pearls and perils in epigenetic psychopathology. In: GUZE SB, EARLS FJ, BARRETT JE, ed. American Psychopathological Association Series. Childhood psychopathology and development. New York: Raven Press, 1983:286-299.
11. MCGUE M, GOTTESMAN II, RAO DC. The transmission of schizophrenia under a multifactorial threshold model. Am J Hum Genet 1983;35:1161-1178.
12. MCGUFFIN P, FARMER A, GOTTESMAN II. Is there really a split in schizophrenia? The genetic evidence. Br J Psychiatry 1987;150:581-592.
13. FARAONE SV, TSUANG MT. Quantitative models of the genetic transmission of schizophrenia. Psychol Bull 1985;98:41-66.
14. FARAONE SV, LYONS MJ, TSUANG MT. Schizophrenia: mathematical models of genetic transmission. In: TSUANG MT, SIMPSON JC, ed. Nosology, epidemiology and genetics. Amsterdam: Elsevier Science Publishers, 1988:501-530.
15. RISCH N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222-228.
16. CLONINGER CR. Turning point in the design of linkage studies of schizophrenia. Am J Med Genet Neuropsychiatr Genet 1994;54:83-92.
17. SEIDMAN LJ. The neuropsychology of schizophrenia: a neurodevelopmental and case study approach. J Neuropsychiatry 1990;2:301-312.
18. WEINBERGER DR. Schizophrenia as a neurodevelopmental disorder: a review of the concept. In: HIRSCH SR, WEINBERGER DR, ed. Schizophrenia. London: Blackwood Press, 1994:293-323.
19. WEINBERGER DR. Neurodevelopmental perspectives on schizophrenia. In: BLOOM FE, KUPFER DJ, ed. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995:1171-1183.
20. GOLDMAN-RAKIC PS. More clues to 'latent' schizophrenia point to developmental origins. Am J Psychiatry 1995;152:1701-1703.
21. BOGERTS B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull 1993;19:431-445.
22. SHENTON ME, WIBLE CG, MCCARLEY RW. A review of magnetic resonance imaging studies of brain abnormalities in schizophrenia. In: KRISHNAN KRR, DORAISWAMY PM, ed. Brain imaging in clinical psychiatry. New York: Marcel Dekker, Inc., 1997:297-380.
23. LIPSKA BK, WEINBERGER DR. Cortical regulation of the mesolimbic dopamine system: implications for schizophrenia. In: KALIVAS PW, BARNES CD, ed. Limbic motor circuits and neuropsychiatry. Boca Raton, FL: CRC Press, 1993:329-349.
24. LIPSKA BK, WEINBERGER DR. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Dev Brain Res 1993;75:213-222.
25. COYLE J. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 1996;3:241-253.
26. KIM J, KORNHUBER H, SHCMID-BURGK W, HOLLANDER B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980;20:379-383.
27. OLNEY J, FARBER N. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998-1007.
28. WYATT RJ. Early intervention for schizophrenia: can the course of the illness be altered? Biol Psychiatry 1995;38: 1-3.
29. GREEN AI, SCHILDKRAUT JJ. Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. Harv Rev Psychiatry 1995;3:1-9.
30. MCGLASHAN TH, JOHANNESSEN JO. Early detection and intervention with schizophrenia: rationale. Schizophr Bull 1996;22:201-222.
31. VAUGHN C, LEFF J. The measurement of expressed emotion in the families of psychiatric patients. Br J Soc Clin Psychol 1976;15:157-165.
32. KAVANAGH DJ. Recent developments in expressed emotion and schizophrenia. Br J Psychiatry 1992;160:601-620.
33. DOANE J, WEST K, GOLDSTEIN M, RODNICK E, JONES J. Parental communication deviance and affective style: predictors of subsequent schizophrenia-spectrum disorders in vulnerable adolescents. Arch Gen Psychiatry 1981;38:679-685.
34. WYNNE L, SINGER M. Thought disorder and family relations of schizophrenics. I. A research strategy. Arch Gen Psychiatry 1963;9:191.
35. SINGER MT, WYNNE LC. Thought disorder and family relations of schizophrenics. III. Methodology using protective techniques. Arch Gen Psychiatry 1965;12:187-212.
36. DOCHERTY NM. Cognitive characteristics of the parents of schizophrenic patients. J Nerv Ment Dis 1994;182:443-451.
37. ERLENMEYER-KIMLING L, CORNBLATT BA. Summary of attentional findings in the New York high-risk project. J Psychiatr Res 1992;26:405-426.
38. CORNBLATT B, WINTERS L, ERLENMEYER-KIMLING L. Attentional markers of schizophrenia: evidence from the New York high-risk study. In: SCHULZ SC, TAMMINGA CA, ed. Schizophrenia: scientific progress. New York: Oxford University Press, 1989:83-92.
39. NUECHTERLEIN KH. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. J Abnorm Psychol 1983;92:4-28.
40. HARVEY P, WINTERS K, WEINTRAUB S, NEALE JM. Distractibility in children vulnerable to psychopathology. J Abnorm Psychol 1981;90:298-304.
41. CORNBLATT B, ERLENMEYER-KIMLING L. Early attentional predictors of adolescent behavioral disturbances in children at risk for schizophrenia. In: WATT NF et al., ed. Children at risk for schizophrenia: a longitudinal perspective. New York: Cambridge University Press, 1984: 198-211.
42. SCHREIBER H, STOLZ-BORN G, HEINRICH H, KORNHUBER HH, BORN J. Attention, cognition, and motor perseveration in adolescents at genetic risk for schizophrenia and control subjects. Psychiatr Res 1992;44:125-140.
43. ASARNOW JR, STEFFY RA, MACCRIMMON DJ, CLEGHORN JM. An attentional assessment of foster children at risk for schizophrenia. In: WYNNE LC, CROMWELL RL, MATTHYSSE S, ed. The nature of schizophrenia: new approaches to research and treatment. New York: John Wiley & Sons, 1978:339-358.
44. WINTERS KC, STONE AA, WEINTRAUB S, NEALE JM. Cognitive and attentional deficits in children vulnerable to psychopathology. J Abnorm Child Psychol 1981;9:435-453.
45. NEALE J. Information processing and vulnerability: high-risk research. In: GOLDSTEIN MJ, ed. Preventive intervention in schizophrenia: are we ready? Washington, DC: US Government Printing Office, 1982:78-89.
46. VARTIOVAARA A, MAKELA S, PYKALAINEN R. Effects of parental schizophrenia on children's mental health. Psychiatr Fenn 1990;21:87-103.
47. ORVASCHEL H, MEDNICK S, SCHULSINGER F, ROCK D. The children of psychiatrically disturbed parents: differences as a function of the sex of the sick parent. Arch Gen Psychiatry 1979;36:691-695.
48. RUTSCHMANN J, CORNBLATT BA, ERLENMEYER-KIMLING L. Auditory recognition memory in adolescents at risk for schizophrenia: report on a verbal continuous recognition task. Psychiatr Res 1980;3:151-161.
49. DRISCOLL RM. Intentional and incidental learning in children vulnerable to psychopathology. In: WATT NF et al., ed. Children at risk for schizophrenia: a longitudinal perspective. New York: Cambridge University Press, 1984:320-325.
50. ASARNOW JR, GOLDSTEIN MJ. Schizophrenia during adolescence and early adulthood: a developmental perspective on risk research. Clin Psychol Rev 1986;6:211-235.
51. LIFSHITZ M, KUGELMASS S, KAROV M. Perceptual-motor and memory performance of high-risk children. Schizophr Bull 1985;11:74-84.
52. MARCUS J, HANS SL, NAGLER S, AUERBACH JG, MIRSKY AF, AUBREY A. Review of the NIMH Israeli kibbutz-city study and the Jerusalem infant development study. Schizophr Bull 1987;13:425-438.
53. ERLENMEYER-KIMLING L, CORNBLATT B, FRIEDMAN D et al. Neurological, electrophysiological, and attentional deviations in children at risk for schizophrenia. In: HENN FA, NASRALLAH HA, ed. Schizophrenia as a brain disease. New York: Oxford University Press, 1982:61-98.
54. NEUCHTERLEIN KH, DAWSON ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984;10:160-203.
55. AUERBACH J, HANS S, MARCUS J. Neurobehavioral functioning and social behavior of children at risk for schizophrenia. Isr J Psychiatry Rel Sci 1993;30:40-49.
56. KREMEN WS, SEIDMAN LJ, PEPPLE JR, LYONS MJ, TSUANG MT, FARAONE SV. Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull 1994;20:103-119.
57. SMALL NE. Positive and negative symptoms and children at-risk for schizophrenia. Dissert Abstracts Int 1990;51:1005.
58. DWORKIN RH, CORNBLATT BA, FRIEDMANN R et al. Childhood precursors of affective vs. social deficits in adolescents at risk for schizophrenia. Schizophr Bull 1993;19:563-577.
59. DWORKIN R, LEWIS J, CORNBLATT B, ERLENMEYER-KIMLING L. Social competence deficits in adolescents at risk for schizophrenia. J Nerv Ment Dis 1994;182:103-108.
60. LEDINGHAM J. Recent developments in high-risk research. In: KAZDIN BB, LA AE, ed. Advances in clinical child psychology. New York: Plenum Press, 1990:91-137.
61. ASARNOW J. Children at risk for schizophrenia: converging lines of evidence. Schizophr Bull 1988;14:613-631.
62. FISH B, MARCUS J, HANS SL, AUERBACH JG, PERDUE S. Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem infant development study. Arch Gen Psychiatry 1992;49:221-235.
63. OLIN S-cS, MEDNICK SA. Risk factors of psychosis: identifying vulnerable populations premorbidly. Schizophr Bull 1996;22:223-240.
64. WALKER E, LEWINE RJ. Prediction of adult-onset schizophrenia from childhood home movies of the parents. Am J Psychiatry 1990;147:1052-1056.
65. HANS SL, MARCUS J, HENSON L, AUERBACH JG, MIRSKY AF. Interpersonal behavior of children at risk for schizophrenia. Psychiatry 1992;55:314-335.
66. BARON M, GRUEN R, ASNIS L, KANE J. Familial relatedness of schizophrenia and schizotypal states. Am J Psychiatry 1983;140:1437-1442.
67. BARON M, GRUEN R, RAINER JD, KANE J, ASNIS L, LORD S. A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia. Am J Psychiatry 1985;142:447-455.
68. KENDLER KS, MASTERSON CC, UNGARO R, DAVIS KL. A family history study of schizophrenia-related personality disorders. Am J Psychiatry 1984;141:424-427.
69. KENDLER KS, NEALE, MC, WALSH D. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. Am J Psychiatry 1995;152:749-754.
70. SIEVER LJ, SILVERMAN JM, HORVATH TB et al. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Arch Gen Psychiatry 1990;47:634-640.
71. GUNDERSON JG, SIEVER LJ, SPAULDING E. The search for a schizotype: crossing the border again. Arch Gen Psychiatry 1983;40:15-22.
72. KETY SS. Schizophrenic illness in the families of schizophrenic adoptees: findings from the Danish national sample. Schizophr Bull 1988;14:217-222.
73. SIEVER LJ, GUNDERSON JG. Genetic determinants of borderline conditions. Schizophr Bull 1979;5:59-86.
74. TORGERSEN S. Relationship of schizotypal personality disorder to schizophrenia: genetics. Schizophr Bull 1985;11:554-563.
75. KENDLER KS, MASTERSON CC, DAVIS KL. Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia, and medical illness. Br J Psychiatry 1985;147:524.
76. KETY SS, ROSENTHAL D, WENDER PH, SCHULSINGER F. The types and prevalence of mental illness in the biological and adoptive families of adopted schizophrenics. J Psychiatr Res 1968;1:345-362.
77. KETY SS, ROSENTHAL D, WENDER PH, SCHULSINGER F, JACOBSON B. Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: a preliminary report based on psychiatric interviews. In: RIEVE RR, ROSENTHAL D, BRILL H, ed. Genetic research in psychiatry. Baltimore, MD: Johns Hopkins University Press, 1975:147-165.
78. TSUANG MT, GILBERTSON MW, FARAONE SV. Genetic transmission of negative and positive symptoms in the biological relatives of schizophrenics. In: MARNEROS A, TSUANG MT, ANDREASEN N, ed. Positive vs. negative schizophrenia. New York: Springer-Verlag, 1991:265-291.
79. ANDREASEN NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa, 1983.
80. ANDREASEN NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, TA: University of Iowa, 1984.
81. GROVE WM, LEBOW BS, CLEMENTZ, BA, CERRI A, MEDUS C, IACONO WG. Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study. J Abnorm Psychol 1991;100:115-121.
82. KATSANIS J, IACONO WG, BEISER M. Anhedonia and perceptual aberration in first-episode psychotic patients and their relatives. J Abnorm Psychol 1990;99:202-206.
83. CLEMENTZ BA, GROVE WM, KATSANIS J, IACONO WG. Psychometric detection of schizotypy: perceptual aberration and physical anhedonia in relatives of schizophrenics. J Abnorm Psychol 1991;100:607-612.
84. LEVY DL, HOLZMAN PS, MATTHYSSE S, MENDELL NR. Eye tracking and schizophrenia: a selective review. Schizophr Bull 1994;20:47-62.
85. CORNBLATT BA, KEILP JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 1994;20:31-46.
86. CATTS SV, MCCONAGHY N, WARD PB, FOX AM, HADZIPAVLOVIC D. Allusive thinking in parents of schizophrenics. Meta-analysis. J Nerv Ment Dis 1993;181:298-302.
87. SHENTON ME, SOLOVAY MR, HOLZMAN PS, COLEMAN M, GALE HJ. Thought disorder in the relatives of psychotic patients. Arch Gen Psychiatry 1989;46:897-901.
88. FRIEDMAN D, SQUIRES-WHEELER E. Event-related potentials (ERPs) as indicators of risk for schizophrenia. Schizophr Bull 1994;20:63-74.
89. WEINBERGER DR, DELISI LE, NEOPHYTIDES AN, WYATT RJ. Familial aspects of CT scan abnormalities in chronic schizophrenic patients. Psychiatr Res 1981;4:65-71.
90. REVELEY AM, REVELEY MA, CLIFFORD RM. Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1982;i:540-541.
91. CANNON TD, MEDNICK SA, PARNAS J, SCHULSINGER F, PRAESTHOLM J, VESTERGAARD A. Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors. Arch Gen Psychiatry 1993;50:551-564.
92. SEIDMAN LJ, FARAONE SV, GOLDSTEIN JM et al. Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients. Biol Psychiatry 1996;39:602.
93. LIDDLE PF, SPENCE SA, SHARMA T. A PET study of obligate carriers of the predisposition to schizophrenia. Schizophr Res 1995;15:90.
94. WALDO MC, CAWTHRA E, ADLER LE et al. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophr Res 1994;12:93-106.
95. BERMAN KF, TORREY EF, DANIEL DG, WEINBERGER DR. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 1992;49:927-934.
96. MEDNICK SA, PARNAS J, SCHULSINGER R. The Copenhagen High-Risk Project. Schizophr Bull 1987;13:485-495.
97. SHERRINGTON R, BRYNJOLFSSON J, PETURSSON H et al. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 1988;336:164-167.
98. GURLING HMD, SHARMA T. Genetic linkage analysis and clinical approaches to the resolution of heterogeneity in the schizophrenias. In: GERSHON ES, CLONINGER CR, ed. Genetic approaches to mental disorders. Washington, DC: American Psychiatric Press, 1994:231-251.
99. BARR CL, KENNEDY JL, PAKSTIS AJ et al. Progress in a genome scan for linkage in schizophrenia in a large Swedish kindred. Am J Med Genet Neuropsychiatr Genet 1994;54:51-58.
100. COON H, JENSEN S, HOLIK J et al. A genomic scan for genes predisposing to schizophrenia. Am J Med Genet Neuropsychiatr Genet 1994;54:59-71.
101. COON H, HOLIK J, HOFF M et al. Analysis of chromosome 22 markers in 9 schizophrenia pedigrees. Am J Med Genet Neuropsychiatr Genet 1994;54:72-79.
102. POLYMEROPOULOS MH, COON H, BYERLEY W et al. Search for a schizophrenia susceptibility locus on human chromosome 22. Am J Med Genet Neuropsychiatr Genet 1994;54:93-99.
103. VALLADA HP, COLLIER D, SHAM P et al. Linkage studies on chromosome 22 in familial schizophrenia. Am J Med Genet Neuropsychiatr Genet 1995;60:139-146.
104. PULVER AE, KARAYIORGOU M, LASSETER VK et al. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1. Part 2. Am J Med Genet Neuropsychiatr Genet 1994;54:44-50.
105. KALSI G, BRYNJOLFSSON J, BUTLER R et al. Linkage analysis of chromosome 22q12-13 in a United Kingdom/Icelandic sample of 23 multiplex schizophrenia families. Am J Med Genet Neuropsychiatr Genet 1995;60:298-301.
106. Schizophrenia Collaborative Linkage Group (Chromosome 22). A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus at chromosome 22q12. Am J Med Genet Neuropsychiatr Genet 1996;67:40-45.
107. WANG S, SUN C, WALCZAK C et al. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nature Genet 1995;10:41-46.
108. STRAUB RE, MACLEAN CJ, O'NEILL FA et al. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nature Genet 1995;11:287-293.
109. MOISES HW, YANG L, KRISTBJARNARSON H et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nature Genet 1995;11:321-324.
110. SCHWAB SG, ALBUS M, HALLMAYER J et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nature Genet 1995;11:325-327.
111. MOWRY BJ, NANCARROW DJ, LENNON DP et al. Schizophrenia susceptibility and chromosome 6p24-22. Nature Genet 1995;11:233-234.
112. ANTONARAKIS SE, BLOUIN J-L, PULVER AE et al. Schizophrenia susceptibility and chromosome 6p24-22. Nature Genet 1995;11:235-236.
113. GURLING H, KALSI G, CHEN AH et al. Schizophrenia susceptibility and chromosome 6p24-22. Nature Genet 1995;11:234-235.
114. 114. RISCH N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet Epidemiol 1990;7:3-7.
115. FARAONE SV, SEIDMAN LJ, KREMEN WS et al. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol 1995;104:286-304.
116. TSUANG MT, FARAONE SV, LYONS MJ. Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatr Neurol Sci 1993;243:131-142.
117. MATTHYSSE S. Genetic linkage and complex diseases: a comment. Genet Epidemiol 1990;7:29-31.
118. AROLT V, LENCER R, ACHIM N et al. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am J Med Genet Neuropsychiatr Genet 1996;67:560-563.
119. COON H, PLAETKE R, HOLIK J et al. Use of a neurophysiological trait in linkage analysis of schizophrenia. Biol Psychiatry 1993;34:277-289.